The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Whole exome and transcriptome sequencing of colorectal and pancreatic cancer.
 
Gargi D. Basu
Employment - Ashion Analytics
 
Kevin Drenner
No Relationships to Disclose
 
Audrey Ozols
Employment - Ashion Analytics
Consulting or Advisory Role - Da Vinci
 
Candyce M Bair
Employment - Ashion Analytics
Patents, Royalties, Other Intellectual Property - Heliae Development LLC.
 
Tracey White
Employment - Ashion Analytics
 
Janine R LoBello
Employment - Ashion Analytics
Leadership - Ashion Analytics
Consulting or Advisory Role - Castle Biosciences
 
Thomas Royce
Employment - Ashion Analytics
Leadership - Ashion Analytics
 
Sunil Sharma
Stock and Other Ownership Interests - Bauerfeind; Beta Cat Pharmaceuticals; ConverGene; Elevar Therapeutics; HLB; Proteus Digital Health; Salarius Pharmaceuticals; Stingray Therapeutics
Honoraria - Array BioPharma; Bauerfeind; Dracen; Exelixis; Exelixis; Hengrui Therapeutics; Loxo; Tarveda Therapeutics
Consulting or Advisory Role - Bauerfeind; Dracen
Research Funding - AADi; Celgene; City of Hope; City of Hope; Hengrui Therapeutics; Honor Health; Honor Health; Inhibrx; Merck; Novartis; OncoMed; Plexxikon; Syndax; Tesaro; Toray Industries
Patents, Royalties, Other Intellectual Property - International PCT Application No. PCT/US20/13618 Title: BISPHOSPHONATE CONJUGATES AND USES THEREOF; Provisional Application No. 62/961,930. Title: PepSeq as a platform to identify synthetic molecular binding agents; Provisional application number: 62/818,037 Title: Trisubstituted Pyrazolo [1, 5-a] Pyrimidine Compounds and Methods of Use Thereof
Travel, Accommodations, Expenses - Bauerfeind; Dracen; Exelixis; Hengrui Therapeutics; Loxo; Tarveda Therapeutics